Halodoc, a prominent digital healthcare ecosystem platform based in Jakarta, has successfully concluded its latest funding round, securing a substantial investment of USD 100 million.
The Series D funding round was orchestrated by PT Astra International Tbk, who spearheaded the venture through its subsidiary, PT Astra Digital Internasional. The round saw noteworthy participation from Openspace and Novo Holdings.
Expansion Plans Fueled by New Funding
With the infusion of funds from this latest round, Halodoc is poised to propel its expansion efforts to new heights. The company aims to not only extend its operational reach but also to enhance and diversify its array of services. This strategic move is set to solidify Halodoc’s position as a premier digital healthcare solution provider.

Guided by the vision of its CEO & Co-Founder Jonathan Sudharta, Halodoc stands as a trailblazing digital healthcare ecosystem platform. Its core objective is to foster holistic wellness by offering an integrated suite of services, ranging from preventive measures to curative solutions, all within a comprehensive application.
Innovative Offerings Shaping the Future of Healthcare
Halodoc’s commitment to advancing healthcare goes beyond its digital platform. The company’s initiatives encompass enhancing digital health literacy among the Indonesian population through effective health communication, education, and information dissemination. Additionally, Halodoc is dedicated to augmenting its services in innovative ways:
Home Lab: This pioneering preventive healthcare service empowers users to perform health tests conveniently and securely from their own homes.
My Insurance: Halodoc has seamlessly integrated with prominent insurance partners, providing users with easy access to cashless outpatient benefits.
Collaboration for Technological Progress
Halodoc’s partnership with the government underscores its dedication to driving technological advancement within the healthcare sector. The company is actively engaged in collaborative efforts to establish telehealth regulations, a pivotal step outlined by the Ministry of Health (MoH) of the Republic of Indonesia.
Diverse Array of Early Investors
The success of Halodoc’s journey is underpinned by the support of its early investors. Notable names include Acrew Capital, Argor (previously Go-Ventures), Allianz X, Bangkok Bank, Bill & Melinda Gates Foundation, HEAL Partners, Intudo Ventures, Korea Investment Partners, Prudential, TMI (Telkomsel venture arm), Singtel Innov8, UOB Venture Management, Uni-President, Global Investama Andalan, and InvestIdea.
Halodoc’s recent achievement of securing USD 100 million in Series D funding marks a significant milestone in its journey toward revolutionizing digital healthcare. With strategic expansion plans, innovative services, and collaborative efforts with the government, the company is well-positioned to shape the future of healthcare in Indonesia and beyond.
TL;DR:
Jakarta-based digital healthcare platform Halodoc has successfully concluded its Series D funding round, garnering USD 100 million in investments. Led by PT Astra International Tbk and supported by Openspace and Novo Holdings, the funding will fuel the company’s expansion plans and the enhancement of its healthcare services. Halodoc, under the leadership of CEO & Co-Founder Jonathan Sudharta, offers a comprehensive digital healthcare ecosystem, including Home Lab and My Insurance services. The company is also working closely with the Indonesian government to advance healthcare technology. Early investors in Halodoc include prominent names like Acrew Capital, Allianz X, and the Bill & Melinda Gates Foundation. This funding milestone signals Halodoc’s dedication to reshaping the healthcare landscape.
Hi, I’m Oren, founder at BIGINTRO, a content strategy agency that helps B2B companies drive growth. We develop search, social, PR, and content marketing strategies tailored to business goals. I also have a dog named Milo.